Peter D'Adamo

  • Citations Per Year
Learn More
Charcot- Marie-Tooth disease type 2 is clinically and genetically heterogeneous. A particular clinical subtype of autosomal dominant Charcot-Marie-Tooth disease type 2, characterized by diaphragm and vocal cord paralysis, is labelled Charcot-Marie-Tooth disease type 2C but no genetic locus has been mapped for this form. We describe the first European family(More)
Determining ABH secretor phenotype and/or Lewis (Le) blood group status can be useful to the metabolically-oriented clinician. For example, differences in ABH secretor status drastically alter the carbohydrates present in body fluids and secretions; this can have profound influence on microbial attachment and persistence. Lewis typing is one genetic marker(More)
The properties of lectins have been known for some time and extensively studied. Their ability to cause disease and to function as markers which delineate specific pathological processes has been reported, but until recently, the role of lectins in the treatment of disease has only been suggested by a variety of sources. It wasn't until the introduction of(More)
  • 1